Alaunos Therapeutics Inc (TCRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 200 | 200 | 200 | 200 | 200 |
| Gross Profit | 200 | 200 | 200 | 200 | 200 |
| Operating Expenses | 18,496 | 23,783 | 39,043 | 21,927 | 23,166 |
| Operating Income | -18,296 | -23,583 | -38,843 | -21,727 | -22,966 |
| Other Income | -396 | 10,784 | 8,618 | 3,903 | -647 |
| Pre-tax Income | -18,692 | -12,799 | -30,225 | -17,824 | -23,613 |
| Net Income Continuous | -18,692 | -12,799 | -30,225 | -17,824 | -23,613 |
| Net Income | $-18,692 | $-12,799 | $-30,225 | $-17,824 | $-23,613 |
| EPS Basic Total Ops | -32.98 | -22.49 | -55.47 | -34.48 | -44.98 |
| EPS Basic Continuous Ops | -33.73 | -23.15 | -55.92 | -33.97 | -45.09 |
| EPS Diluted Total Ops | -32.98 | -22.49 | -55.47 | -34.48 | -44.98 |
| EPS Diluted Continuous Ops | -33.73 | -23.15 | -55.92 | -33.97 | -45.09 |
| EBITDA(a) | $-18,099 | $-23,384 | $-38,651 | $-21,526 | $-22,819 |